Kcp Biotech Limited, a prominent player in the biotechnology sector, is headquartered in India and operates extensively across various regions. Founded in 1991, the company has established itself as a leader in the development and manufacturing of biopharmaceuticals, particularly in the fields of vaccines and therapeutics. Kcp Biotech is renowned for its innovative core products, which include advanced vaccine formulations and bioprocessing solutions that cater to both domestic and international markets. The company’s commitment to quality and research excellence has positioned it favourably within the industry, earning recognition for its contributions to public health. With a focus on sustainable practices and cutting-edge technology, Kcp Biotech Limited continues to drive advancements in biotechnology, solidifying its reputation as a trusted name in the field.
How does Kcp Biotech Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Kcp Biotech Limited's score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Kcp Biotech Limited reported total carbon emissions of approximately 418,460,000 kg CO2e for Scope 1 and about 25,010,000 kg CO2e for Scope 2. This reflects a significant increase in emissions compared to 2021, when Scope 1 emissions were around 342,909,000 kg CO2e and Scope 2 emissions were approximately 21,368,000 kg CO2e. Kcp Biotech Limited has not disclosed any Scope 3 emissions data, nor have they set specific reduction targets or climate pledges. The company operates as a current subsidiary and inherits its emissions data from its parent organisation, Kcp Biotech Limited, with no additional climate initiatives reported from higher levels in the corporate structure. Overall, while Kcp Biotech Limited has made strides in reporting its emissions, the lack of reduction targets or commitments indicates an area for potential improvement in their climate strategy.
Access structured emissions data, company-specific emission factors, and source documents
2021 | 2022 | |
---|---|---|
Scope 1 | 342,909,000 | 000,000,000 |
Scope 2 | 21,368,000 | 00,000,000 |
Scope 3 | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Kcp Biotech Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.